FDMT: 4D Molecular Therapeutics Inc
FDMT exchange rate has changed by -13.69% for today. During the day, the instrument was traded at a low of 8.55 and at a high of 10.02.
Follow 4D Molecular Therapeutics Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
FDMT News
- 4D Molecular Therapeutics, Inc. (FDMT) Presents at Jefferies Global Healthcare Conference 2026 Transcript
- 4D Molecular Therapeutics, Inc. (FDMT) Presents at Bank of America Global Healthcare Conference 2026 Transcript
- 4D Molecular Therapeutics, Inc. (FDMT) Reports Q1 Loss, Lags Revenue Estimates
- Aclaris Therapeutics (ACRS) Reports Q1 Loss, Beats Revenue Estimates
- electroCore (ECOR) Moves 7.1% Higher: Will This Strength Last?
- 4D Molecular Therapeutics, Inc. (FDMT) Q4 Earnings and Revenues Beat Estimates
- 4D Molecular Therapeutics, Inc. (FDMT) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
- 4D Molecular Therapeutics, Inc. (FDMT) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow (NASDAQ:FDMT) 2026-01-19
- RBC Capital reiterates Outperform rating on 4D Molecular stock at $32
- Ashoo Gupta of 4D Molecular Therapeutics sells $3.3k in FDMT stock
- 4D Molecular Therapeutics: Jury Still Out On CF Gene Therapy After Dense Data Drop (NASDAQ:FDMT)
- BlackBerry, FedEx, Nike And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Aimei Health Technology (NASDAQ:AFJK), Aura Biosciences (NASDAQ:AURA)
- Avago and Oracle among market cap stock movers on Wednesday
- 4D Molecular Therapeutics, Inc. (FDMT) Discusses Interim Phase I Data From AEROW Trial in Cystic Fibrosis and Platform Potential Transcript
- 4D Molecular Therapeutics, Inc. (FDMT) Discusses Interim Phase I Data From AEROW Trial in Cystic Fibrosis and Platform Potential - Slideshow (NASDAQ:FDMT) 2025-12-17
- 4D Molecular Therapeutics, Inc. (FDMT) Presents at Jefferies London Healthcare Conference 2025 Transcript
- 4d Molecular Therapeutics chief legal officer sells $17k in stock
- 4D Molecular Therapeutics appoints Kristian Humer as chief financial officer
- 4D Molecular Therapeutics stock price target raised by RBC to $32 on funding
Frequently Asked Questions
What is FDMT stock price today?
4D Molecular Therapeutics Inc stock is priced at 8.64 today. It trades within 8.55 - 10.02, yesterday's close was 10.01, and trading volume reached 1425. The live price chart of FDMT shows these updates.
Does 4D Molecular Therapeutics Inc stock pay dividends?
4D Molecular Therapeutics Inc is currently valued at 8.64. Dividend policy depends on the company, while investors also watch -23.54% and USD. View the chart live to track FDMT movements.
How to buy FDMT stock?
You can buy 4D Molecular Therapeutics Inc shares at the current price of 8.64. Orders are usually placed near 8.64 or 8.94, while 1425 and -12.99% show market activity. Follow FDMT updates on the live chart today.
How to invest into FDMT stock?
Investing in 4D Molecular Therapeutics Inc involves considering the yearly range 6.96 - 12.34 and current price 8.64. Many compare -11.75% and 13.24% before placing orders at 8.64 or 8.94. Explore the FDMT price chart live with daily changes.
What are 4D Molecular Therapeutics Inc stock highest prices?
The highest price of 4D Molecular Therapeutics Inc in the past year was 12.34. Within 6.96 - 12.34, the stock fluctuated notably, and comparing with 10.01 helps spot resistance levels. Track 4D Molecular Therapeutics Inc performance using the live chart.
What are 4D Molecular Therapeutics Inc stock lowest prices?
The lowest price of 4D Molecular Therapeutics Inc (FDMT) over the year was 6.96. Comparing it with the current 8.64 and 6.96 - 12.34 shows potential long-term entry points. Watch FDMT moves on the chart live for more details.
When did FDMT stock split?
4D Molecular Therapeutics Inc has gone through stock splits historically. These changes are visible in , 10.01, and -23.54% after corporate actions.
- Previous Close
- 10.01
- Open
- 9.93
- Bid
- 8.64
- Ask
- 8.94
- Low
- 8.55
- High
- 10.02
- Volume
- 1.425 K
- Daily Change
- -13.69%
- Month Change
- -11.75%
- 6 Months Change
- 13.24%
- Year Change
- -23.54%
- Act
- Fcst
- Prev